Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study

Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study

Abstract Background and objective Evidence for the treatment of multisystem inflammatory syndrome in children (MIS-C) is lacking. Anakinra, which targets IL-1-mediated inflammation, is reserved for refractory cases of MIS-C; however, its use in the treatment of MIS-C is not clearly established. Pati...

Full description

Bibliographic Details
Main Authors: Brian L.P. Dizon, Christopher Redmond, Emily C. Gotschlich, Sangeeta Sule, Tova Ronis, Kathleen M. Vazzana, Matthew A. Sherman, Rachael Connor, Abigail Bosk, Niti Dham, Ashraf S. Harahsheh, Elizabeth Wells, Roberta DeBiasi, Hemalatha Srinivasalu
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Multisystem inflammatory syndrome in children
Cardiac dysfunction
SARS-CoV2
Anakinra
Therapy
Online Access:https://doi.org/10.1186/s12969-023-00858-z

Internet

https://doi.org/10.1186/s12969-023-00858-z

Similar Items